MyoKardia, Inc. et al v. Aurobindo Pharma Ltd. et al
| MyoKardia, Inc. and Bristol-Myers Squibb Company |
| Aurobindo Pharma Ltd. and Aurobindo Pharma USA, Inc. |
| 1:2026cv00847 |
| July 13, 2026 |
| U.S. District Court for the District of Delaware |
| Jennifer L Hall |
| Patent - Abbreviated New Drug Application(ANDA) |
| 35 U.S.C. ยง 271 Patent Infringement |
| None |
Docket Report
RSS Track this Docket
This docket was last retrieved on September 4, 2026. A more recent docket listing may be available from PACER.
| Document Text |
|---|
| Pro Hac Vice Attorney Stanley E. Fisher, Elise M. Baumgarten, Christopher A. Yeager, Richard Hildreth, III & Catherine A. Reid for Bristol-Myers Squibb Company & MyoKardia, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. Associated Cases: 1:26-cv-00847-JLH et al.(slk) |
SO ORDERED, re #9 Motion for Pro Hac Vice Appearance of Attorney Stanley E. Fisher, Elise M. Baumgarten, Christopher A. Yeager, Richard Hildreth III, and Catherine A. Reid filed by MyoKardia, Inc., Bristol-Myers Squibb Company. Ordered by Judge Jennifer L. Hall on 9/2/2026. (ceg)
|
| Filing 10 Pro Hac Vice Fee - Credit Card Payment received for Stanley E. Fisher, Elise M. Baumgarten, Christopher A. Yeager, Richard Hildreth III, and Catherine A. Reid. ( re #9 MOTION for Pro Hac Vice Appearance of Attorney Stanley E. Fisher, Elise M. Baumgarten, Christopher A. Yeager, Richard Hildreth III, and Catherine A. Reid )( Payment of $ 250, receipt number ADEDC-5056099).(Raucci, Anthony) |
| Filing 9 MOTION for Pro Hac Vice Appearance of Attorney Stanley E. Fisher, Elise M. Baumgarten, Christopher A. Yeager, Richard Hildreth III, and Catherine A. Reid - filed by Bristol-Myers Squibb Company, MyoKardia, Inc.. (Raucci, Anthony) |
| Filing 8 WAIVER OF SERVICE returned executed by Bristol-Myers Squibb Company, MyoKardia, Inc.: For Aurobindo Pharma USA, Inc. waiver sent on 7/16/2026, answer due 9/14/2026. (Raucci, Anthony) |
| Filing 7 WAIVER OF SERVICE returned executed by Bristol-Myers Squibb Company, MyoKardia, Inc.: For Aurobindo Pharma Ltd. waiver sent on 7/16/2026, answer due 9/14/2026. (Raucci, Anthony) |
| Case Assigned to Judge Jennifer L. Hall. Please include the initials of the Judge (JLH) after the case number on all documents filed. (nms) |
| Filing 6 Summons Issued as to Aurobindo Pharma Ltd. on 7/14/2026; Aurobindo Pharma USA, Inc. on 7/14/2026. (Attachments: #1 Summons Issued)(jfm) |
| Filing 5 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Bristol-Myers Squibb Company for MyoKardia, Inc. - filed by Bristol-Myers Squibb Company, MyoKardia, Inc.. (jfm) |
| Filing 4 Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 9,585,883 B2; RE50,050 E. (jfm) |
| Filing 3 Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 06/01/2026. Date of Expiration of Patent: U.S. Patent No. 9,585,883 expires on 6/19/2034; and U.S. Reissue Patent RE50,050 expires on 4/28/2036.Thirty Month Stay Deadline: 10/28/2029. (jfm) |
| Filing 2 Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (jfm) |
| Filing 1 COMPLAINT against Aurobindo Pharma Ltd., Aurobindo Pharma USA, Inc. (Filing fee $ 405, receipt number ADEDC-5014858) - filed by Bristol-Myers Squibb Company, MyoKardia, Inc. (Attachments: #1 Exhibits A-B, #2 Civil Cover Sheet)(jfm) |
Access additional case information on PACER
Use the links below to access additional information about this case on the U.S. Court's PACER system. A subscription to PACER is required.
Access this case on the Delaware District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
